Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Insulin Resistance in Idiopathic Oligospermia and Azoospermia

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by The Egyptian IVF-ET Center
Sponsor:
Information provided by (Responsible Party):
Ragaa Mansour, The Egyptian IVF-ET Center
ClinicalTrials.gov Identifier:
NCT01509482
First received: January 6, 2012
Last updated: November 2, 2013
Last verified: October 2013
  Purpose

Insulin resistance in men can be the underlying major factor in reproductive abnormalities ( chronic hypospermatogenesis ) as well as metabolic abnormalities similar to polycystic ovarian syndrome ( PCOS ) in women.


Condition Intervention
Insulin Resistance
Oligospermia
Azoospermia
Other: blood samples
Other: Blood samples

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Insulin Resistance : a New Diagnosis of the Pathogenesis of Idiopathic Oligozoospermia and Non Obstructive Azoospermia

Resource links provided by NLM:


Further study details as provided by The Egyptian IVF-ET Center:

Primary Outcome Measures:
  • serum insulin [ Time Frame: one month ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Fasting Glucose [ Time Frame: one month ] [ Designated as safety issue: No ]
  • cholesterol [ Time Frame: one month ] [ Designated as safety issue: No ]
  • high density lipoprotein ( HDL) [ Time Frame: one month ] [ Designated as safety issue: No ]
  • Low density lipoprotein ( LDL ) [ Time Frame: one month ] [ Designated as safety issue: No ]
  • testosterone [ Time Frame: one month ] [ Designated as safety issue: No ]
  • Triglycerides [ Time Frame: One month ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2012
Estimated Study Completion Date: April 2014
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
insulin resistance
unexplained oligospermia and azoospermia
Other: blood samples
blood samples to test for primary and secondary outcome measures
Other Name: Unexplained oligospermia and azoospermia
Fertile males
Healthy Men with proven fertility
Other: Blood samples
IR Cholesterol HDL LDL Fasting Glucose Triglycerides
Other Name: Hypospermatogenesis

Detailed Description:

During the past decade IR has been recognized as a major contributor to the pathogenesis of chronic anovulation, hyperandrogenism and metabolic abnormalities associated with PCOS . Theoretically IR in men may result in a similar reproductive abnormalities ( chronic hypospermatogenesis ) as well as other metabolic abnormalities similar to what happens in PCOS in women .

  Eligibility

Ages Eligible for Study:   25 Years to 55 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Infertile men

Criteria

Inclusion Criteria:

  • sperm count less than 10 million per milliliter
  • non-obstructive azoospermia

Exclusion Criteria:

  • high FSH ( > 10 mIU/ ml )
  • high prolactin ( > 36 mIU/ml )
  • abnormal karyotype
  • AZF
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01509482

Contacts
Contact: Ragaa Mansour, MD,PhD 2012 212 2299 ragaa.mansour@gmail.com
Contact: Ragaa Mansour, MD,PhD 202 2525 4955 ragaa.mansour@gmail.com

Locations
Egypt
The Egyptian IVF-ET center Recruiting
Cairo, Egypt, 11431
Contact: Ragaa Mansour       ragaa.mansour@gmail.com   
Principal Investigator: Ragaa Mansour, MD,PhD         
Sponsors and Collaborators
The Egyptian IVF-ET Center
Investigators
Principal Investigator: Ragaa Mansour, MD,PhD The Egyptian IVF-ET Center
  More Information

No publications provided

Responsible Party: Ragaa Mansour, Director, the Egyptian IVF-ET center, The Egyptian IVF-ET Center
ClinicalTrials.gov Identifier: NCT01509482     History of Changes
Other Study ID Numbers: insulin resistance
Study First Received: January 6, 2012
Last Updated: November 2, 2013
Health Authority: Egypt: Institutional Review Board

Keywords provided by The Egyptian IVF-ET Center:
insulin resistance
unexplained azoospermia
unexplained oligospermia

Additional relevant MeSH terms:
Azoospermia
Insulin Resistance
Oligospermia
Genital Diseases, Male
Glucose Metabolism Disorders
Hyperinsulinism
Infertility
Infertility, Male
Metabolic Diseases
Insulin
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 20, 2014